Posted Sep. 24, 2013 at 4:31 p.m.

Premium Lock Quintiles to test for cancer biomarkers to find best therapy for patients

Published: 2013-09-24 16:31:52
Updated: 2013-09-24 16:31:52

Quintiles' headquarters       Quintiles' headquarters

Quintiles (NYSE:Q) wants to find out if "pre-profiling" cancer patients to to get the genomic profile of tumors can help develop better, more targeted cancer therapies. Read more about a studt its doing with US Oncology Research....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders